For example, suppression of lipid metabolizing enzymes (IVA phospholipase A2) reprogrammed effector T cells and thus blocking CD8+ T‐cell senescence and boosts antitumor immunity and immunotherapeutic effects in melanoma and breast cancer.123. This evidence concerns the gene CD8A and breast cancer.